Showing results (641-650 of 661) with videos related to
Sort By:
Pageof 67
Nature Cancer|April 16, 2025
Dual modulation of cytotoxic and checkpoint receptors tunes the efficacy of adoptive Delta One T cell therapy against colorectal cancerRafael Blanco-Domínguez, Leandro Barros, Mariana Carreira, et al.Nature Cancer|March 18, 2025
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.Nature Cancer|March 18, 2025
Engineered bacteria for near-infrared light-inducible expression of cancer therapeuticsLongliang Qiao, Lingxue Niu, Zhihao Wang, et al.Nature Cancer|March 25, 2025
CAR T or NK cells targeting mismatched HLA-DR molecules in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantShunya Ikeda, Kana Hasegawa, Yosuke Kogue, et al.Nature Cancer|June 6, 2024
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistanceTommaso Scolaro, Marta Manco, Mathieu Pecqueux, et al.Nature Cancer|June 3, 2024
Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironmentKevin M Tharp, Kelly Kersten, Ori Maller, et al.Nature Cancer|January 6, 2026
De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell functionNils Bessler, Amber K L Wezenaar, Hendrikus C R Ariese, et al.Nature Cancer|January 16, 2026
Cellular neighborhoods in cancerLichun Ma, Barbara Xiong, Meng Liu, et al.Nature Cancer|April 18, 2024
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemiaHannah Lawson, James P Holt-Martyn, Vilma Dembitz, et al.Nature Cancer|April 23, 2024
Circadian regulation of cancer stem cells and the tumor microenvironment during metastasisYu Wang, Rajesh Narasimamurthy, Meng Qu, et al.Pageof 67